Soluble TNF-α but not transmembrane TNF-α sensitizes T cells for enhanced activation-induced cell death

European Journal of Immunology

Volumn 39, Issue 11, 2009, Pages 3171-3180

  Müller, Stefan ^a   Rihs, Silvia ^a   Schneider, Johanna M Dayer ^a   Paredes, Bruno E ^a   Seibold, Ingeborg ^a   Brunner, Thomas ^a   Mueller, Christoph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Activation induced cell death; CD4+ T cells; Colitis; TNF ; Transmembrane TNF

Indexed keywords

MEMBRANE PROTEIN; MUTANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DISEASE COURSE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SEPARATION; COLITIS; FLOW CYTOMETRY; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 70449368147     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939554     Document Type: Article

References (45)

1. Kollias, G., Douni, E., Kassiotis, G. and Kontoyiannis, D., On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 1999. 169: 175-194.
2. Moss, M. L., Jin, S. L., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C. et al., Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997. 385: 733-736. (Pubitemid 27098095)
3. Perez, C., Albert, I., DeFay, K., Zachariades, N., Gooding, L. and Kriegler, M., A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 1990. 63: 251-258. (Pubitemid 20355446)
4. Mueller, C., Corazza, N., Trachsel-Loseth, S., Eugster, H. P., Buhler-Jungo, M., Brunner, T. and Imboden, M. A., Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNFalpha) mediates effects distinct from those of wild-type TNFalpha in vitro and in vivo. J. Biol. Chem. 1999. 274: 38112-38118.
5. Alexopoulou, L., Pasparakis, M. and Kollias, G., A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol. 1997. 27: 2588-2592.
6. Kusters, S., Tiegs, G., Alexopoulou, L., Pasparakis, M., Douni, E., Kunstle, G., Bluethmann, H. et al., In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 1997. 27: 2870-2875.
7. Ruuls, S. R., Hoek, R. M., Ngo, V. N., McNeil, T., Lucian, L. A., Janatpour, M. J., Korner, H. et al., Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation. Immunity 2001. 15: 533-543. (Pubitemid 33016439)
8. Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torrance, D. S. et al., Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 1994. 370: 218-220. (Pubitemid 24236777)
9. Olleros, M. L., Guler, R., Corazza, N., Vesin, D., Eugster, H. P., Marchal, G., Chavarot, P. et al., Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. J. Immunol. 2002. 168: 3394-3401. (Pubitemid 34250403)
10. Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J. et al., TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 1998. 4: 78-83.
11. Yang, X. D., Tisch, R., Singer, S.M., Cao, Z. A., Liblau, R. S., Schreiber, R. D. and McDevitt, H. O., Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J. Exp. Med. 1994. 180: 995-1004.
12. Togbe, D., Grivennikov, S. I., Noulin, N., Couillin, I., Maillet, I., Jacobs, M., Maret, M. et al., T cell-derived TNF down-regulates acute airway response to endotoxin. Eur. J. Immunol. 2007. 37: 768-779.
13. Cope, A. P., Studies of T-cell activation in chronic inflammation. Arthritis Res. 2002. 4: S197-S211.
14. Cope, A. P., Liblau, R. S., Yang, X. D., Congia, M., Laudanna, C., Schreiber, R. D., Probert, L. et al., Chronic tumor necrosis factor alters T cell responses by attenuating T cell receptor signaling. J. Exp. Med. 1997. 185: 1573-1584.
15. Isomäki, P., Panesar, M., Annenkov, A., Clark, J., Foxwell, B., Chernajovsky, Y. and Cope, A., Prolonged exposure of T cells to TNF downregulates TCR zeta and expression of the TCR/CD3 complex at the cell surface. J. Immunol. 2001. 166: 5495-5507. (Pubitemid 32374171)
16. Clark, J. M., Annenkov, A. E., Panesar, M., Isomaki, P., Chernajovsky, Y. and Cope, A. P., T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 2004. 101: 1696-1701.
17. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J. et al., Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995. 373: 441-444.
18. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J., Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995. 377: 348-351.
19. Rensing-Ehl, A., Frei, K., Flury, R., Matiba, B., Mariani, S. M., Weller, M., Aebischer, P. et al., Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 1995. 25: 2253-2258.
20. Powrie, F., Leach, M. W., Mauze, S., Caddle, L. B. and Coffman, R. L., Phenotypically distinct subsets of CD4+T cells induce or protect from chronic intestinal inflammation in C. B-17 scidmice. Int. Immunol. 1993. 5: 1461-1471.
21. Morrissey, P. J., Charrier, K., Braddy, S., Liggitt, D. andWatson, J. D., CD4+ T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4+T cells. J. Exp. Med. 1993. 178: 237-244.
22. Owens, T., Wekerle, H. and Antel, J., Genetic models for CNS inflammation. Nat. Med. 2001. 7: 161-166.
23. Corazza, N., Brunner, T., Buri, C., Rihs, S., Imboden, M. A., Seibold, I. and Mueller, C., Transmembrane tumor necrosis factor is a potent inducer of colitis even in the absence of its secreted form. Gastroenterology 2004. 127: 816-825. (Pubitemid 39208414)
24. Zhang, H. G., Liu, C., Su, K., Yu, S., Zhang, L., Zhang, S., Wang, J. et al., A membrane form of TNF-alpha presented by exosomes delays T cell activation-induced cell death. J. Immunol. 2006. 176: 7385-7393. (Pubitemid 43849040)
25. Kassiotis, G. and Kollias, G., Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 2001. 193: 427-434.
26. Hunger, R. E., Carnaud, C., Garcia, I., Vassalli, P. and Mueller, C., Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur. J. Immunol. 1997. 27: 255-261.
27. Green, E. A., Eynon, E. E. and Flavell, R. A., Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 1998. 9: 733-743.
28. Satoh, J., Seino, H., Abo, T., Tanaka, S., Shintani, S., Ohta, S., Tamura, K. et al., Recombinant human tumor necrosis factor alpha suppresses autoimmune diabetes in nonobese diabetic mice. J. Clin. Invest. 1989. 84: 1345-1348.
29. Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O. and Acha Orbea, H., Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl. Acad. Sci. USA 1990. 87: 968-972.
30. Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway C. A., Jr. and Flavell, R. A., Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 1996. 184: 1963-1974.
31. Davies, S. J., Lim, K. C., Blank, R. B., Kim, J. H., Lucas, K. D., Hernandez, D. C., Sedgwick, J. D. and McKerrow, J. H., Involvement of TNF in limiting liver pathology and promoting parasite survival during schistosome infection. Int. J. Parasitol. 2004. 34: 27-36.
32. Zganiacz, A., Santosuosso, M., Wang, J., Yang, T., Chen, L., Anzulovic, M., Alexander, S. et al., TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J. Clin. Invest. 2004. 113: 401-413.
33. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 1999. 53: 457-465.
34. Butz, E. A. and Bevan, M. J., Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 1998. 8: 167-175. (Pubitemid 28123744)
35. Hildeman, D. A., Zhu, Y., Mitchell, T. C., Bouillet, P., Strasser, A., Kappler, J. and Marrack, P., Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 2002. 16: 759-767. (Pubitemid 34786475)
36. Zhou, T., Edwards C. K., III, Yang, P., Wang, Z., Bluethmann, H. and Mountz, J. D., Greatly accelerated lymphadenopathy and autoimmune disease in lpr mice lacking tumor necrosis factor receptor I. J. Immunol. 1996. 156: 2661-2665. (Pubitemid 126660608)
37. Tartaglia, L. A., Pennica, D. and Goeddel, D. V., Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 1993. 268: 18542-18548.
38. Weiss, T., Grell, M., Siemienski, K., Muhlenbeck, F., Durkop, H., Pfizenmaier, K., Scheurich, P. and Wajant, H., TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J. Immunol. 1998. 161: 3136-3142. (Pubitemid 28425742)
39. Dayer Schneider, J., Seibold, I., Saxer-Sekulic, N., Paredes, B. E., Saurer, L. and Mueller, C., Lack of TNFR2 expression by CD4(+) T cells exacerbates experimental colitis. Eur. J. Immunol. 2009. 39: 1743-1753.
40. Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N. and Braun, M. M., Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 2001. 345: 1098-1104.
41. Ohashi, P. S., T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev. Immunol. 2002. 2: 427-438.
42. Elzey, B. D., Griffith, T. S., Herndon, J. M., Barreiro, R., Tschopp, J. and Ferguson, T. A., Regulation of Fas ligand-induced apoptosis by TNF. J. Immunol. 2001. 167: 3049-3056. (Pubitemid 32852541)
43. Müller, S., Bühler-Jungo, M. and Mueller, C., Intestinal intraepithelial lymphocytes exert potent protective cytotoxic activity during an acute virus infection. J. Immunol. 2000. 164: 1986-1994. (Pubitemid 30108754)
44. Müller, S., Lory, J., Corazza, N., Griffiths, G. M., Z'graggen, K., Mazzucchelli, L., Kappeler, A. and Mueller, C., Activated CD4+and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. Am. J. Pathol. 1998. 152: 261-268.
45. -/-) mice upon transfer of CD4 (1)CD45RB(hi) T cells. J. Exp. Med. 1999. 190: 1479-1492.